Track the Raia Drogasil S.A. share price and the full directors' dealings record of the company, a listed equity based in Brazil. Shares trade on BR BR, under the authority of CVM (Brazil). Operating in the Health Care sector, Raia Drogasil S.A. has logged 5,719 insider filings. Market capitalisation: €31.7bn. The latest transaction was filed on 10 July 2026 (Compra à vista (Crédito)). Among the most active insiders: Anonymous (Controlador ou Vinculado). Every trade is free.
5,719
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Raia Drogasil S.A. Buy (bullish), based on 15 analysts. Average price target: R$25.79.
18Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,371 of 26,212 companies
51.3
score / 100
Value
50
Quality
53
FCF yld0.3%
Earn yld4.1%
EV/EBITDA11.4x
ROE19%
Gross mgn29%
Net mgn2.9%
Debt/EBITDA2.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
RAIA DROGASIL S.A. is a Brazilian company specializing in the retail of pharmaceuticals and health products. It primarily operates through a network of pharmacies across the country.